|
|
|
|
Vol. 301, Issue 1, 129-137, April 2002
Departments of Pharmacology (S.N.H., S.E.H., N.M.N.) and Physiology
and Biophysics (K.N.R., E.O.F.), University of Washington, Seattle,
Washington; and Department of Pediatric Anesthesia, Children Hospital,
Seattle, Washington (A.Z.)
Although the M2 muscarinic acetylcholine receptor (mAChR)
is the predominant functional mAChR subtype in the heart, some
responses of the cardiovascular system to acetylcholine (ACh) may be
mediated by other mAChR subtypes. The potential effect of
M1 mAChR on heart function was investigated using
M1 knockout (M1-KO) mice. In vivo cardiodynamic
analysis showed that basal values of heart rate (HR), developed left
ventricular pressure (DLVP), left ventricular dP/dtmax (LV
dP/dtmax), and mean blood pressure (MBP) were similar between wild-type (WT) and M1-KO mice. Injection of the
putative M1-selective agonist
4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) produced an increase in LV dP/dtmax,
DLVP, HR, and MBP in WT mice but did not affect hemodynamic function in
the M1-KO mice. The stimulatory effect of McN-A-343 in WT
mice was blocked by pretreatment with propranolol, indicating that
stimulation of the M1 mAChRs on sympathetic postganglionic
neurons evoked release of catecholamines. Intravenous injection of ACh
in both WT and M1-KO mice caused atrioventricular
conduction block, without a significant change in the frequency of
atrial depolarization, or atrial fibrillation. Immunoprecipitation and
reverse transcriptase-polymerase chain reaction failed to detect
the expression of M1 mAChR in cardiac tissue from WT mice.
The carbachol-induced increase of phospholipase C activity in cardiac
tissues was not different between WT and M1-KO mice. These
results demonstrate that 1) activation of M1 mAChR subtype
on sympathetic postganglionic cells results in catecholamine-mediated
cardiac stimulation, 2) M1 mAChR is not expressed in mouse
heart, and 3) administration of ACh to mice induces arrhythmia.
This article has been cited by other articles:
![]() |
J. A.I. Virag, M. L. Rolle, J. Reece, S. Hardouin, E. O. Feigl, and C. E. Murry Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair: Effects on Cell Proliferation, Scar Contraction, and Ventricular Function Am. J. Pathol., November 1, 2007; 171(5): 1431 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fu, X. Huang, L. Piao, A. N. Lopatin, and R. R. Neubig Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2532 - H2539. [Abstract] [Full Text] [PDF] |
||||